Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,686 | 2,583 | 7,379 | -55,177 | -41,104 |
| Depreciation Amortization | 682 | 487 | 245 | 990 | 745 |
| Accounts payable and accrued liabilities | 769 | 1,513 | 507 | -185 | -129 |
| Other Working Capital | -1,402 | -1,758 | -1,825 | 346 | -397 |
| Other Operating Activity | -19,106 | -20,332 | -14,922 | 27,003 | 19,676 |
| Operating Cash Flow | $-27,743 | $-17,507 | $-8,616 | $-27,023 | $-21,209 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -151 | -34 | -3 | -16 | -13 |
| Investing Cash Flow | $-151 | $-34 | $-3 | $-16 | $-13 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7,500 | -5,000 | -2,500 | -9,167 | -6,667 |
| Common Stock Issued | 19,881 | 20,574 | 630 | 103,447 | 9,034 |
| Other Financing Activity | -178 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $12,203 | $15,574 | $-1,870 | $94,280 | $2,367 |
| Beginning Cash Position | 102,920 | 102,920 | 102,920 | 35,679 | 35,679 |
| End Cash Position | 87,229 | 100,953 | 92,431 | 102,920 | 16,824 |
| Net Cash Flow | $-15,691 | $-1,967 | $-10,489 | $67,241 | $-18,855 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,743 | -17,507 | -8,616 | -27,023 | -21,209 |
| Capital Expenditure | -178 | -34 | -3 | -16 | -13 |
| Free Cash Flow | -27,921 | -17,541 | -8,619 | -27,039 | -21,222 |